SCHEMBL31338732

SCHEMBL31338732

O=C=Nc1ccc(OCCCCCC(=O)OCCOC(=O)CCCCCOc2ccc(N=C=O)cc2)cc1

nearest known ligand 0.41

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.41
HDAC1 Q13547 7/20 0.41
HDAC2 Q92769 6/20 0.41
HDAC3 O15379 3/20 0.41
HDAC4 P56524 3/20 0.41
HDAC7 Q8WUI4 3/20 0.41
HDAC10 Q969S8 3/20 0.41
HDAC11 Q96DB2 3/20 0.41
HDAC8 Q9BY41 3/20 0.41
HDAC6 Q9UBN7 3/20 0.41
HDAC9 Q9UKV0 3/20 0.41
HDAC5 Q9UQL6 3/20 0.41
HTT P42858 2/20 0.41
DGKA P23743 1/20 0.41
LTA4H P09960 1/20 0.40
PPARA Q07869 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16261774 0.96 HDAC1 (0.40) GAAHDAC1HDAC2HDAC3HDAC4
SCHEMBL16270526 0.95 HDAC1 (0.39) GAAHDAC1HDAC2HDAC3HDAC4
SCHEMBL16262380 0.90 KMT2A (0.49) GAAHDAC1HDAC2HDAC3HDAC4
SCHEMBL830677 0.89 HDAC1 (0.45) GAAHDAC1HDAC2HDAC3HDAC4
SCHEMBL16270246 0.88 HDAC1 (0.38) GAAHDAC1HDAC2HDAC3HDAC4
SCHEMBL10703892 0.86 TSHR (0.50) GAAHDAC1HDAC2HDAC3HDAC4
SCHEMBL7602206 0.86 TSHR (0.50) GAAHDAC1HDAC2HDAC3HDAC4
SCHEMBL13611324 0.85 PRSS1 (0.44) HDAC6DGKAL3MBTL1
SCHEMBL13224227 0.84 GAA (0.38) GAALTA4HL3MBTL1
SCHEMBL10341873 0.84 CYP3A4 (0.52) GAAPPARAL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260022207-A1 POLYMER AND USE THEREOF SHENZHEN SENIOR TECHNOLOGY MATERIAL CO LTD (CN) 2026-01-22 US disclosed
WO-2025024656-A1 POLYESTER URETHANE BIORESORBABLE ELASTOMERS WITH MICROSTRUCTURES FOR TUNABLE DRUG RELEASE AND TUNABLE DEGRADATION SOLESIS, INC. (US) 2025-01-30 WO disclosed
US-20250034331-A1 POLYESTER URETHANE BIORESORBABLE ELASTOMERS WITH MICROSTRUCTURES FOR TUNABLE DRUG RELEASE AND TUNABLE DEGRADATION SOLESIS LLC 2025-01-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250034331-A1 POLYESTER URETHANE BIORESORBABLE ELASTOMERS WITH MICROSTRUCTURES FOR TUNABLE DRUG RELEASE AND TUNABLE DEGRADATION PUF60, UTS2R, UROD GAA 2685/4885HDAC1 2865/4885HDAC2 2367/4885
US-20260022207-A1 POLYMER AND USE THEREOF CCNB1, CCNB2, C1S GAA 4856/4885HDAC1 4471/4885HDAC2 4444/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.